HIGHLIGHTS
- who: Can, Xu and Wei, Cao from the Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China have published the research work: Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer, in the Journal: Journal of Oncology of 30/08/2022
- what: The authors identified the molecular subtypes of ovarian cancer and evaluated their relationship with patients' prognosis and clinical features by analyzing the DNA methylation and transcriptome of ovarian cancer patients. The model was then constructed using 5foldcross-validation, and the confidence intervals under each lambda . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.